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Abstract      Orphan nuclear receptor TR3 (also known as Nur77) is a product of an immediate-early gene 
encoded by NR4A1, and belongs to the steroid/thyroid/retinoid nuclear receptor superfamily. TR3 is widely 
involved in the regulation of biological processes, such as cell proliferation, differentiation, apoptosis and 
autophagy. It is considered as an important molecular target for anti-tumor drug design. TR3, as a transcription 
factor, regulates gene transcription and expression through targeting to the DNA response elements, and also 
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functions as a regulator through interaction with other proteins in distinct subcellular localizations. Here, we review 
the functions and regulatory mechanisms of TR3 in tumorigenesis, and progress in the development of therapeutics 
with TR3 as the target.





1   TR3的结构特征
TR3在结构上具有核受体的典型特征, 主要分
为N端的转录激活区(transactivation domain, TAD)、
中部的DNA结合区(DNA binding domain, DBD)以及



















































TAD: N端转录激活区; DBD: DNA结合区; LBD: 配体结合区。
TAD: transactivation domain; DBD: DNA binding domain; LBD: ligand binding domain.
图1   TR3结构示意图



















































蓝色为先前报道的LBD结构(PDB: 2QW4); 红色(Molecule I)和灰色(Molecule II)为我们报道的LBD结构(PDB: 3V3E)。
Blue: crystal structure of LBD reported previously (PDB: 2QW4); Red (molecule I) and grey (Molecule II): crystal structures of LBD reported by our 
group (PDB: 3V3E).
 图2   不同的TR3 LBD晶体结构图 
Fig.2    Crystal structures of TR3 LBD
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2.2   抑癌作用
TR3促进细胞凋亡的作用首先在T淋巴细胞
的阴性选择(negative selection)中被发现[37]。1994








































































TR3能募集SP1(specificity protein 1)、 SIN3A(swi-
independent-3 transcription regulator family member 
A)、 CoREST(corepressor of REST)、 LSD1(lysine(K)-
specifi c demethylase 1A)和HDAC1(lysine(K)-specifi c 
demethylase 1A)到 TGF-β(transforming growth 
factor-β)靶向基因启动子上, 组成转录抑制复合体, 
从而削弱TGF-β的促纤维化作用[62]。 



































































EBP homologous protein)的表达, 最终促进肝癌细胞
凋亡[69]。













TR3的T88位点发生磷酸化, 蛋白稳定性增强; 继而, 
发生磷酸化修饰的TR3募集转录辅抑制因子N-CoR, 
通过结合到下游基因BRE(brain and reproductive 



















表1   靶向TR3信号通路的肿瘤药物











NuBCP-9[66] Mimic peptide Apoptosis Mimics TR3 interaction with Bcl-2 Breast, lung, cervical
Paclitaxel[72] Mimic peptide Apoptosis Mimics TR3 interaction with Bcl-2 Ovarian
Fenretinide[81] Retinoid TR3-mediated apoptosis Induction of TR3 expression, TR3 
mitochondiral targeting
Liver











Plant extract derivates TR3-mediated apoptosis Negative regulation on antiapoptotic 
genes
Bladder, breast, colon, 
pancreatic
Acetylshikonin derivatives[53] Plant extract derivates TR3-mediated apoptosis TR3 mitochondiral targeting, interaction 
with Bcl-2
Lung, cervical
Cytosporone B and analogs[41,73] Fungus extract TR3-mediated apoptosis TR3 mitochondiral targeting, negative 
regulation on antiapoptotic genes
Gastric
ATE-i2-b4 and H-9[77] Digitalis-like 
compounds
Inhibit TR3-mediated cell 
cycle progression
β-catenin degradadion Colon, cervical
VP-16 (Etoposide)[42] Chemotherapeutic TR3-mediated apoptosis Induction of TR3 expression, TR3 
cytoplasmic targeting
Gastric
Panobinostat[83] Chemotherapeutic TR3-mediated apoptosis TR3 mitochondiral targeting, interaction 
with Bcl-2
T-cell lymphoma
FK506 and HA1004[70] Chemotherapeutic Restore sensitivity to 
ionomycin-induced 
apoptosis
Inhibits TR3 DNA-binding activity and 
TR3 nuclear import
Thymic lymphoma
Cisplatin[45-47] Chemotherapeutic TR3-mediated apoptosis TR3 mitochondiral targeting, negative 






Chemotherapeutic TR3-mediated apoptosis Induction of TR3 expression, TR3 










































SRC2(steroid receptor coactivator 2)的募集。在肿瘤




































































过线粒体外膜(mitochondrial outer membrane, MOM)
进入线粒体内膜(mitochondrial inner membrane, 
MIM)与线粒体膜孔通道复合体(mitochondria l 
permeability transition pore complex, mPTPC)的关键



















MOM: 线粒体外膜; MIM: 线粒体内膜; ΔΨm: 线粒体膜电位。
MOM: mitochondrial outer membrane; MIM: mitochondrial inner membrane; ΔΨm: mitochondrial membrane potential.
 图3   TR3介导细胞死亡方式与其线粒体内外膜定位的关系
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